secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0001437749-25-012475
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02, 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma enters $4.5M PNC credit facility; replaces prior debt
--------------------------------------------------------------------------

- New $4M revolving line of credit and $500K convertible equipment line from PNC Bank (SOFR+250bps).
- Maturity date April 5, 2026; borrowed funds for working capital and equipment purchases.
- Prior credit facility fully repaid and terminated; payoff amount was $7,864.51 on April 15, 2025.
- Reimbursement agreement covers standby/commercial letters of credit up to $1M sublimit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774925012475/0001437749-25-012475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774925012475/inbp20250417c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-012475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer